Healthcare / Healthcare PlansShenzhen
$7.16
-0.07 (-0.97%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-127.3M · quality 77.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
15/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$7.0B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-40.1%
↓Gross Margin
21.2%
↓Debt/Equity
0.41
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+4.1%
FCF CAGR
—
FCF margin
-36.3%
FCF / Net income
0.32x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $350.4M · net income $-404.0M · FCF $-127.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $350.4M | $350.4M | $356.9M | $330.1M | $311.1M |
| Net Income | $-404.0M | $-404.0M | $-10.4M | $-79.8M | $-84.3M |
| EBITDA | $-349.4M | $-349.4M | $32.4M | $-39.5M | $-41.6M |
| EPS | -0.41 | -0.41 | -0.01 | -0.09 | -0.09 |
| Gross Margin | 21.2% | 21.2% | 15.3% | 24.8% | 20.7% |
| Operating Margin | -40.5% | -40.5% | -38.7% | -32.3% | -35.3% |
| Net Margin | -115.3% | -115.3% | -2.9% | -24.2% | -27.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.41 | 0.41 | 0.20 | 0.14 | 0.08 |
| Current Ratio | 2.68 | 2.68 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-127.3M | $-127.3M | $-120.1M | $-154.3M | $-197.9M |
| Returns | |||||
| ROE | -40.1% | -40.1% | -0.7% | -5.6% | -11.9% |
| Valuation | |||||
| EV/EBITDA | — | — | 300.25 | — | — |
| P/B | 6.96 | 6.96 | 7.05 | 7.81 | 12.76 |
| Growth & Yield | |||||
| Revenue Growth | -1.8% | -1.8% | 8.1% | 6.1% | — |
| EPS Growth | -3792.5% | -3792.5% | 87.9% | 5.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-31.7%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.01 → -0.41
Residual
-31.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.